The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Prognostic effect of the sixth and seventh American Joint Committee on Cancer TNM staging systems on esophageal cancer patients treated with chemoradiotherapy.
M. Nomura
No relevant relationships to disclose
K. Shitara
No relevant relationships to disclose
T. Kodaira
No relevant relationships to disclose
S. Hatooka
No relevant relationships to disclose
A. Mizota
No relevant relationships to disclose
C. Kondoh
No relevant relationships to disclose
T. Yokota
No relevant relationships to disclose
D. Takahari
No relevant relationships to disclose
T. Ura
No relevant relationships to disclose
K. Muro
No relevant relationships to disclose